0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Benign Prostatic Hyperplasia (BPH) Laser Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-21T14000
Home | Market Reports | Health| Men s Health
Global Benign Prostatic Hyperplasia BPH Laser Therapy Market Research Report 2023
BUY CHAPTERS

Benign Prostatic Hyperplasia (BPH) Laser Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21T14000
Report
October 2024
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market Size

The global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy was estimated to be worth US$ 7460 million in 2023 and is forecast to a readjusted size of US$ 11720 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030

Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market

Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market

BPH or benign prostatic hyperplasia or hypertrophy is a benign enlargement of the prostate.BPH Laser Therapy is a minimally invasive procedure for BPH (benign prostatic hyperplasia) that uses laser energy to remove enlarged prostate tissue, resulting in an open channel for urine flow-through and a quick return to a life with dramatically improved BPH symptoms.Benign prostate hyperplasia (BPH), while not cancer, can causes symptoms such as bladder stones, blood in the urine and an inability to urinate.
The global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy focuses on providing therapeutic solutions for the treatment of BPH using laser technologies. BPH, also known as prostate gland enlargement, is a common condition among aging men that can cause urinary symptoms and affect quality of life. Laser therapy offers a minimally invasive approach to treat BPH, providing benefits such as reduced bleeding and quicker recovery compared to traditional surgical methods.
Market Overview: The market for BPH laser therapy is driven by the increasing prevalence of BPH and the growing demand for minimally invasive treatment options. The market includes various laser technologies and devices used for the treatment of BPH.
Laser Treatment Options: BPH laser therapy involves the use of laser energy to remove or vaporize excess prostate tissue, thus relieving symptoms and improving urinary flow. Different laser modalities used for BPH treatment include GreenLight laser (laser vaporization), holmium laser enucleation of the prostate (HoLEP), thulium laser, and others.
Advantages Over Traditional Surgical Methods: BPH laser therapy offers several advantages over traditional surgical methods. It is minimally invasive, resulting in shorter hospital stays, reduced risk of complications, and faster recovery times. Laser therapy also allows for precise tissue ablation, minimizing damage to surrounding structures.
Market Factors: The market growth for BPH laser therapy is driven by factors such as the increasing geriatric population, rising awareness about minimally invasive treatment options, technological advancements in laser devices, and the proven efficacy of laser therapy in BPH management.
Key Players: The market includes medical device companies that specialize in developing and marketing laser systems for BPH treatment. These companies may offer a range of laser devices, accessories, and associated services.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Benign Prostatic Hyperplasia (BPH) Laser Therapy by region & country, by Type, and by Application.
The Benign Prostatic Hyperplasia (BPH) Laser Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Benign Prostatic Hyperplasia (BPH) Laser Therapy.
Market Segmentation

Scope of Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market Report

Report Metric Details
Report Name Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market
Forecasted market size in 2030 US$ 11720 million
CAGR 6.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Holmium Laser
  • Thulium Laser
  • Green Light Laser
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boston Scientific, Agiliti Health, Inc., Endo Pharmaceuticals Inc., HealthTronics, Inc., OmniGuide, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Coloplast Corp, Medifocus Inc., Biolitec, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Benign Prostatic Hyperplasia (BPH) Laser Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Benign Prostatic Hyperplasia (BPH) Laser Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Benign Prostatic Hyperplasia (BPH) Laser Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market size in 2030?

Ans: The Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market size in 2030 will be US$ 11720 million.

Who are the main players in the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market report?

Ans: The main players in the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market are Boston Scientific, Agiliti Health, Inc., Endo Pharmaceuticals Inc., HealthTronics, Inc., OmniGuide, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Coloplast Corp, Medifocus Inc., Biolitec, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics

What are the Application segmentation covered in the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market report?

Ans: The Applications covered in the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market report?

Ans: The Types covered in the Benign Prostatic Hyperplasia (BPH) Laser Therapy - Market report are Holmium Laser, Thulium Laser, Green Light Laser, Others

1 Market Overview
1.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Product Introduction
1.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Forecast
1.3 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Trends & Drivers
1.3.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Trends
1.3.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Drivers & Opportunity
1.3.3 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Challenges
1.3.4 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Players Revenue Ranking (2023)
2.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company (2019-2024)
2.3 Key Companies Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Benign Prostatic Hyperplasia (BPH) Laser Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Benign Prostatic Hyperplasia (BPH) Laser Therapy
2.6 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Competitive Analysis
2.6.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Laser Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Holmium Laser
3.1.2 Thulium Laser
3.1.3 Green Light Laser
3.1.4 Others
3.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type
3.2.1 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application
4.2.1 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region
5.1.1 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (2019-2024)
5.1.3 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (2025-2030)
5.1.4 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
5.2.2 North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
5.3.2 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
5.5.2 South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value
6.3 United States
6.3.1 United States Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.3.2 United States Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.4.2 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.5.2 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.6.2 Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.7.2 South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019-2030
6.9.2 India Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Profile
7.1.2 Boston Scientific Main Business
7.1.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.1.4 Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Boston Scientific Recent Developments
7.2 Agiliti Health, Inc.
7.2.1 Agiliti Health, Inc. Profile
7.2.2 Agiliti Health, Inc. Main Business
7.2.3 Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.2.4 Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Agiliti Health, Inc. Recent Developments
7.3 Endo Pharmaceuticals Inc.
7.3.1 Endo Pharmaceuticals Inc. Profile
7.3.2 Endo Pharmaceuticals Inc. Main Business
7.3.3 Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.3.4 Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 HealthTronics, Inc. Recent Developments
7.4 HealthTronics, Inc.
7.4.1 HealthTronics, Inc. Profile
7.4.2 HealthTronics, Inc. Main Business
7.4.3 HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.4.4 HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 HealthTronics, Inc. Recent Developments
7.5 OmniGuide
7.5.1 OmniGuide Profile
7.5.2 OmniGuide Main Business
7.5.3 OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.5.4 OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 OmniGuide Recent Developments
7.6 Olympus Corporation
7.6.1 Olympus Corporation Profile
7.6.2 Olympus Corporation Main Business
7.6.3 Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.6.4 Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Olympus Corporation Recent Developments
7.7 Richard Wolf GmbH
7.7.1 Richard Wolf GmbH Profile
7.7.2 Richard Wolf GmbH Main Business
7.7.3 Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.7.4 Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Richard Wolf GmbH Recent Developments
7.8 Lumenis
7.8.1 Lumenis Profile
7.8.2 Lumenis Main Business
7.8.3 Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.8.4 Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Lumenis Recent Developments
7.9 Urologix, LLC
7.9.1 Urologix, LLC Profile
7.9.2 Urologix, LLC Main Business
7.9.3 Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.9.4 Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Urologix, LLC Recent Developments
7.10 Coloplast Corp
7.10.1 Coloplast Corp Profile
7.10.2 Coloplast Corp Main Business
7.10.3 Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.10.4 Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Coloplast Corp Recent Developments
7.11 Medifocus Inc.
7.11.1 Medifocus Inc. Profile
7.11.2 Medifocus Inc. Main Business
7.11.3 Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.11.4 Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Medifocus Inc. Recent Developments
7.12 Biolitec
7.12.1 Biolitec Profile
7.12.2 Biolitec Main Business
7.12.3 Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.12.4 Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 Biolitec Recent Developments
7.13 Teleflex Incorporated
7.13.1 Teleflex Incorporated Profile
7.13.2 Teleflex Incorporated Main Business
7.13.3 Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.13.4 Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 Teleflex Incorporated Recent Developments
7.14 Urotech Devices
7.14.1 Urotech Devices Profile
7.14.2 Urotech Devices Main Business
7.14.3 Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.14.4 Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.14.5 Urotech Devices Recent Developments
7.15 BD
7.15.1 BD Profile
7.15.2 BD Main Business
7.15.3 BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.15.4 BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.15.5 BD Recent Developments
7.16 PROCEPT BioRobotics
7.16.1 PROCEPT BioRobotics Profile
7.16.2 PROCEPT BioRobotics Main Business
7.16.3 PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
7.16.4 PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue (US$ Million) & (2019-2024)
7.16.5 PROCEPT BioRobotics Recent Developments
8 Industry Chain Analysis
8.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industrial Chain
8.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Benign Prostatic Hyperplasia (BPH) Laser Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Trends
    Table 2. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Drivers & Opportunity
    Table 3. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Challenges
    Table 4. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Restraints
    Table 5. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Benign Prostatic Hyperplasia (BPH) Laser Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Benign Prostatic Hyperplasia (BPH) Laser Therapy
    Table 10. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Laser Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Boston Scientific Basic Information List
    Table 32. Boston Scientific Description and Business Overview
    Table 33. Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Boston Scientific (2019-2024)
    Table 35. Boston Scientific Recent Developments
    Table 36. Agiliti Health, Inc. Basic Information List
    Table 37. Agiliti Health, Inc. Description and Business Overview
    Table 38. Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Agiliti Health, Inc. (2019-2024)
    Table 40. Agiliti Health, Inc. Recent Developments
    Table 41. Endo Pharmaceuticals Inc. Basic Information List
    Table 42. Endo Pharmaceuticals Inc. Description and Business Overview
    Table 43. Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Endo Pharmaceuticals Inc. (2019-2024)
    Table 45. Endo Pharmaceuticals Inc. Recent Developments
    Table 46. HealthTronics, Inc. Basic Information List
    Table 47. HealthTronics, Inc. Description and Business Overview
    Table 48. HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of HealthTronics, Inc. (2019-2024)
    Table 50. HealthTronics, Inc. Recent Developments
    Table 51. OmniGuide Basic Information List
    Table 52. OmniGuide Description and Business Overview
    Table 53. OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of OmniGuide (2019-2024)
    Table 55. OmniGuide Recent Developments
    Table 56. Olympus Corporation Basic Information List
    Table 57. Olympus Corporation Description and Business Overview
    Table 58. Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Olympus Corporation (2019-2024)
    Table 60. Olympus Corporation Recent Developments
    Table 61. Richard Wolf GmbH Basic Information List
    Table 62. Richard Wolf GmbH Description and Business Overview
    Table 63. Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Richard Wolf GmbH (2019-2024)
    Table 65. Richard Wolf GmbH Recent Developments
    Table 66. Lumenis Basic Information List
    Table 67. Lumenis Description and Business Overview
    Table 68. Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Lumenis (2019-2024)
    Table 70. Lumenis Recent Developments
    Table 71. Urologix, LLC Basic Information List
    Table 72. Urologix, LLC Description and Business Overview
    Table 73. Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Urologix, LLC (2019-2024)
    Table 75. Urologix, LLC Recent Developments
    Table 76. Coloplast Corp Basic Information List
    Table 77. Coloplast Corp Description and Business Overview
    Table 78. Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Coloplast Corp (2019-2024)
    Table 80. Coloplast Corp Recent Developments
    Table 81. Medifocus Inc. Basic Information List
    Table 82. Medifocus Inc. Description and Business Overview
    Table 83. Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Medifocus Inc. (2019-2024)
    Table 85. Medifocus Inc. Recent Developments
    Table 86. Biolitec Basic Information List
    Table 87. Biolitec Description and Business Overview
    Table 88. Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Biolitec (2019-2024)
    Table 90. Biolitec Recent Developments
    Table 91. Teleflex Incorporated Basic Information List
    Table 92. Teleflex Incorporated Description and Business Overview
    Table 93. Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Teleflex Incorporated (2019-2024)
    Table 95. Teleflex Incorporated Recent Developments
    Table 96. Urotech Devices Basic Information List
    Table 97. Urotech Devices Description and Business Overview
    Table 98. Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of Urotech Devices (2019-2024)
    Table 100. Urotech Devices Recent Developments
    Table 101. BD Basic Information List
    Table 102. BD Description and Business Overview
    Table 103. BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of BD (2019-2024)
    Table 105. BD Recent Developments
    Table 106. PROCEPT BioRobotics Basic Information List
    Table 107. PROCEPT BioRobotics Description and Business Overview
    Table 108. PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Benign Prostatic Hyperplasia (BPH) Laser Therapy Business of PROCEPT BioRobotics (2019-2024)
    Table 110. PROCEPT BioRobotics Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Benign Prostatic Hyperplasia (BPH) Laser Therapy Downstream Customers
    Table 114. Benign Prostatic Hyperplasia (BPH) Laser Therapy Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Benign Prostatic Hyperplasia (BPH) Laser Therapy Product Picture
    Figure 2. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Benign Prostatic Hyperplasia (BPH) Laser Therapy Report Years Considered
    Figure 5. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue in 2023
    Figure 7. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Holmium Laser Picture
    Figure 9. Thulium Laser Picture
    Figure 10. Green Light Laser Picture
    Figure 11. Others Picture
    Figure 12. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Clinics
    Figure 16. Product Picture of Others
    Figure 17. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value (%), (2019-2030)
    Figure 30. United States Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 51. Benign Prostatic Hyperplasia (BPH) Laser Therapy Industrial Chain
    Figure 52. Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Global Urological Stone Extraction Basket Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-28D15031
Thu Oct 03 00:00:00 UTC 2024

Add to Cart

Add to Cart